Clinical Trials
9
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
PREDICT-H Study: Prospective Research on Essential Determinants Influencing Complication Trends in Hypospadias - a Landmark Prospective Multicenter Cohort Study Aimed at Improving Outcome Prediction in Hypospadias Surgery
- Conditions
- Hypospadias
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Sidra Medicine
- Target Recruit Count
- 1300
- Registration Number
- NCT07017842
- Locations
- 🇶🇦
Sidra Medicine, Doha, Qatar
Simple Meal Management Using Automated Insulin Delivery System
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Sidra Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT06130215
- Locations
- 🇶🇦
Sidra Medicine, Doha, Qa, Qatar
Simple Initiation of Advanced Hybrid Closed Loop System
- Conditions
- Diabetes type1
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Sidra Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT05069727
- Locations
- 🇶🇦
Sidra Medicine, Doha, Qa, Qatar
An 8-Day Initiation of Advanced Hybrid Closed Loop System In Children and Adolescents
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Sidra Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT04509362
- Locations
- 🇶🇦
Sidra Medicine, Doha, Qa, Qatar
Point of Care Ultrasound to Confirm Endotracheal Tube Cuff Position in Relationship to the Cricoid in Pediatric Population.
- Conditions
- Endotracheal TubeUltrasoundCricoid Cartilage
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Sidra Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT04479839
- Locations
- 🇶🇦
Sidra Medicine, Doha, Qatar
- Prev
- 1
- 2
- Next
News
Sidra Medicine Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism
• Sidra Medicine has successfully conducted Qatar's first industry-sponsored pharmaceutical trial for pediatric congenital hyperinsulinism, marking a significant advancement in treating this rare condition. • The Phase 3 sunRIZE trial, led by Rezolute, aims to evaluate a new, safer, and non-invasive treatment option, potentially reducing the need for invasive pancreatic surgery in affected children. • The trial focuses on clinical trials that will benefit children in the Arab region, particularly those with rare diseases that lack effective treatment, offering new hope for patients and families. • Sidra Medicine was selected as one of 22 leading centers worldwide to participate in the sunRIZE Phase 3 clinical trial, highlighting its growing prominence in pediatric endocrinology.
Sidra Medicine Launches Clinical Trials Program for Rare Pediatric Diseases in the Arab Region
Sidra Medicine initiates a clinical trials program focusing on rare and complex diseases affecting children in the Arab region, addressing a significant data gap.